statview ii for pc (Abacus Concepts)
90
Structured Review
Abacus Concepts
statview ii for pc
Statview Ii For Pc, supplied by Abacus Concepts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statview+ii+for+pc/statview/pm35459112-80-5-9
Average 90 stars, based on 1 article reviews
Statview Ii For Pc, supplied by Abacus Concepts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statview+ii+for+pc/statview/pm35459112-80-5-9
Average 90 stars, based on 1 article reviews
statview ii for pc - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation. Article Snippet: Purpose Our previous study highlighted the potential nerve growth factor (NGF) effect on damaged photoreceptors from a rat model of spontaneous Retinitis Pigmentosa (RP).. Herein, we tested the combined NGF/anti-vascular endothelial growth factor (αVEGF) effect on cultured retinal cells isolated from Royal College of Surgeons (RCS) rats receiving an intravitreal VEGF injection (iv-VEGF) to exacerbate retinal inflammation/neovascularization.. Methods RCS (n = 75) rats were equally grouped as untreated (n = 25), iv-saline (single saline intravitreal injection; n = 25) and iv-VEGF (single VEGF intravitreal injection; n = 25). Article Title: Ocular surface toll like receptors in ageing. Article Snippet: The statistical package used was Article Title: A Simple Spontaneous Vitreal Reflux Collecting Procedure During Intravitreal Injection: Set-Up and Validation Studies. Article Snippet: Aim: To set-up a simple technique for collecting spontaneous vitreal reflux (VR) in patients undergoing intravitreal injection.. Both total protein concentration and vascular endothelial growth factor (VEGF)/ Interleukin 13 (IL13) levels were used to validate the technique.. Methods: Sixty consecutive patients with neovascular age-related macular degeneration (nAMD, vitreal reflux drop, VR) and 10 patients underwent vitrectomy for macular hole (whole vitreous removal) were enrolled for the study as controls. Article Title: NGF Modulates trkA NGFR /p75 NTR in αSMA-Expressing Conjunctival Fibroblasts from Human Ocular Cicatricial Pemphigoid (OCP) Article Snippet: Both molecular and biochemical data (means±SD) were analysed for significant differences (p < .05), by the Article Title: InflammAging at Ocular Surface: Clinical and Biomolecular Analyses in Healthy Volunteers. Article Snippet: The statistical package used was Article Title: Inflammatory mediators in the vitreal reflux of patients with diabetic macular edema. Article Snippet: Purpose To quantify inflammatory, growth/angiogenic, and tissue remodeling mediators in vitreal reflux (VR) in patients with diabetic macular edema (DME), as collected at first and third intravitreal anti-vascular endothelial growth factor (anti-VEGF, ranibizumab) injection.. Methods Thirty (30) consecutive patients (type-2 diabetes mellitus) with visual impairments due to DME and undergoing the first (untreated DME) or the third (treated DME) intravitreal injection of anti-VEGF were included in the study.. At the time of surgery, patients were subjected to clinical assessment and spectral domain-optical coherence tomography (SD-OCT), including central retinal thickness (CRT), macular volume, and outer nuclear layer/retinal pigment epithelial (ONL/RPE) measurements. Article Title: Ocular surface diabetic disease: A neurogenic condition? Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Software:Article Title: Neurotrophic keratopathy: Pros and cons of current treatments. Article Snippet: Background: Several therapeutics have been proposed for neurotrophic keratitis, but no direct comparison among different approaches is available.. Objective: To compare treatment-related problems and outcomes of both traditional and novel therapeutics for neurotrophic keratopathy, focusing on resolution rate, healing time, and recurrence rate.. Data sources: Literature search of published studies between 1980 and 2019 on neurotrophic keratopathy available on PubMed was made without any language constraints but limited to human study participants. |